Hepatic vs. gastrointestinal presystemic extraction of oral midazolam and flurazepam.
An experimental model was developed to elucidate the site of presystemic extraction of drugs with incomplete bioavailability due to high extraction after p.o. dosage. Domestic pigs received single i.v. or p.o. doses of midazolam (1 mg/kg) or flurazepam (2 mg/kg), two benzodiazepine derivatives with high presystemic extraction after p.o. dosage. Multiple blood samples were simultaneously drawn from the portal vein and from a systemic vein during 8 hr after dosage. After i.v. administration, both drugs had high systemic serum clearance, averaging 24 ml/min/kg. Area under the serum concentration curve (AUC) for systemic vs. portal sites was nearly identical for midazolam (769 vs. 737 ng/ml x hr); for flurazepam, systemic AUC exceeded portal AUC (1035 vs. 778 ng/ml x hr, P less than .01). After p.o. dosage, the systemic/portal AUC ratio averaged 0.15 for midazolam and 0.11 for flurazepam; for both drugs, portal AUC after p.o. dosage did not differ significantly from systemic AUC after i.v. administration. Thus, the extensive presystemic extraction of orally administered midazolam and flurazepam are mainly attributable to hepatic biotransformation rather than metabolism either within the gastrointestinal tract or during absorption into the portal circulation.
Ochs
H R
HR
Medizinische und Chirurgische Universitätskliniken, University of Bonn, Federal Republic of Germany.
Greenblatt
D J
DJ
Eichelkraut
W
W
Bakker
C
C
Göbel
R
R
Hahn
N
N
D000284:Administration, Oral; D000818:Animals; D004064:Digestive System / Q000378:metabolism*; D005479:Flurazepam / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008099:Liver / Q000378:metabolism*; D008874:Midazolam / Q000008:administration & dosage / Q000493:pharmacokinetics*; D013552:Swine
D005479:Flurazepam; D008874:Midazolam